The society Mithras presents the first results of phase III evaluating Donesta in postmenopausal women with vasomotor symptoms (VMS)… As a reminder, the program launched in 2019 is being conducted on nearly 2,300 women divided into two separate studies. These studies have
©2022 Boursier.com